Avtozma 20 mg/mL injection (multiple presentations) Images
Generic Name: tocilizumab
This medication has been identified as Avtozma 20 mg/mL injection (multiple presentations). It is supplied by Celltrion USA.
Avtozma is used in the treatment of Giant Cell Arteritis; Rheumatoid Arthritis; COVID-19; Polyarticular Juvenile Idiopathic Arthritis; Juvenile Idiopathic Arthritis and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Avtozma 20 mg/mL injection (multiple presentations) is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Avtozma
- Generic Name
- tocilizumab
- Strength
- 20 mg/mL injection (multiple presentations)
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celltrion USA
- National Drug Code (NDC)
- multiple
See also:
More about Avtozma (tocilizumab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.